This inventor holds 6 USPTO granted patents, plus 1 CIPO patent and 4 EPO patents. Top assignee: Amgen Inc.. Active years: 2015-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Newbury Park, CA (US) (2015 - 2017)
- Fremont, CA (US) (2016 - 2022)
Company Filing History:
Years Active: 2015-2025
Title: The Innovative Contributions of Henry Lin
Introduction
Henry Lin is a prominent inventor based in Fremont, CA. He has made significant contributions to the field of biotechnology, particularly in the area of mammalian cell culture. With a total of 6 patents to his name, Lin's work has advanced the methods used in the production of recombinant proteins.
Latest Patents
Among his latest patents, Lin has developed innovative methods for harvesting mammalian cell cultures. These inventions provide essential techniques and materials for culturing mammalian cells and efficiently harvesting recombinant proteins. His work in this area is crucial for various applications in medicine and research.
Career Highlights
Henry Lin is currently employed at Amgen Inc., a leading biotechnology company known for its commitment to innovation and improving patient outcomes. His role at Amgen allows him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Lin has worked alongside talented colleagues such as Chetan Goudar and Sean Cole. Their combined expertise fosters a collaborative environment that enhances the development of new technologies and methodologies in biotechnology.
Conclusion
Henry Lin's contributions to the field of biotechnology through his patents and work at Amgen Inc. highlight his dedication to innovation. His advancements in mammalian cell culture methods are paving the way for future breakthroughs in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
